Main Directory
Articles 2591
CME 2
eCommerce 0
Medical Web Sites Directory 93
Podcasts 94
Web Design and Hosting 2




ESAs Should Continue to be Used for Anemia in Cancer Patients, Says FDA Advisory Committee
Link ID 4045
Title ESAs Should Continue to be Used for Anemia in Cancer Patients, Says FDA Advisory Committee
Url http://www.medscape.com/viewarticle/571464?src=rss
Description Erythropoiesis-stimulating agents should continue to have an oncology indication, even though questions about their safety remain. Medscape Medical News
Category Articles > Hematology-Oncology
Keywords
Date Mar 15, 2008
Contact Name
Email
Write a Review   Add to My Favorite   Refer it to Friend   Report Broken Link  

Average Visitor Rating: 0.00 (out of 5)
Number of ratings: 0 Votes
Visitor Rating

 Other links at Articles > Hematology-Oncology
1. Lenalidomide Maintenance Improves Overall Survival in Multiple Myeloma
  Treatment with lenalidomide after stem cell transplantation shows a survival benefit in the latest update of the Cancer and Leukemia Group phase 3 trial. Medscape Medical News
Category:   Articles > Hematology-Oncology


2. NCI Cooperative Group Program in Need of an Overhaul
  The Institute of Medicine reports that the NCI Clinical Trials Cooperative Group needs an overhaul of its organization, management, and funding. Medscape Medical News
Category:   Articles > Hematology-Oncology


3. First-Line Arsenic Trioxide Improves Outcomes in APL
  In newly diagnosed patients with acute promyelocytic leukemia (APL), arsenic trioxide given with consolidation therapy improves cure rate and survival. Medscape Medical News
Category:   Articles > Hematology-Oncology


4. Favorable Consolidative Effect of High-Dose Melphalan and Total-Body Irradiation Followed by Autolog
  Follicular lymphomas are the most frequently occurring low-grade lymphomas, and relapse is common. These authors examine a multi-pronged approach to treat relapse. Clinical Lymphoma & Myeloma
Category:   Articles > Hematology-Oncology


5. Variants in Vitamin D Receptor Gene Tied to Breast Cancer Risk
  Certain vitamin D receptor (VDR) gene polymorphisms could affect the risk of breast cancer, as well as the estrogen receptor status of tumors, in postmenopausal women, according to findings from a German study. Reuters Health Information
Category:   Articles > Hematology-Oncology




Home      New Listings      Hot Listings      Top Rated      Editor Pick      Add a Listing      Update a Listing      Get Rated      Upgrade a Listing
Valid XHTML 1.0 Transitional   Valid CSS